Overexpression of transcription factor EGR1 resulting in metabolic reprogramming to oxidative phosphorylation (OXPHOS) has also been recently implicated in BTK-inhibitor resistance in MCL and ABC subtype of DLBCL (15). The gene discussed is BTK; the disease is mantle cell lymphoma.